The Radiopharmaceutical Injectors Market was valued at USD 27.8 billion in 2023 and is projected to grow to USD 52.3 billion by 2032, registering a compound annual growth rate (CAGR) of 7.2% over the forecast period from 2024 to 2032. The market's growth is fueled by the rising demand for diagnostic imaging procedures and targeted cancer therapies, particularly in the areas of nuclear medicine...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian